Table 1 Study participants’ sociodemographic, health, and treatment characteristics by gender
Characteristic | Total sample N = 450 | Female n = 356 | Male n = 94 |
|---|---|---|---|
Age group | |||
 18–24 years | 20 (4.4%) | 11 (3.1%) | 9 (9.6%) |
 25–35 years | 87 (19.3%) | 79 (22.2%) | 8 (8.5%) |
 36–49 years | 223 (49.6%) | 175 (49.2%) | 48 (51.1%) |
 50–60 years | 120 (26.7%) | 91 (25.6%) | 29 (30.9%) |
Marital status | |||
 Married/cohabiting | 196 (43.6%) | 142 (39.9%) | 54 (57.5%) |
 Separated/divorced/widowed | 197 (43.8%) | 173 (48.6%) | 24 (25.5%) |
 Never married | 57 (12.7%) | 41 (11.5%) | 16 (17.0%) |
Education | |||
 Tertiary | 22 (4.9%) | 13 (3.7%) | 9 (9.6%) |
 Secondary | 66 (14.7%) | 42 (11.8%) | 24 (25.5%) |
 Primary | 239 (53.1%) | 180 (50.6%) | 59 (62.8%) |
 None | 123 (27.3%) | 121 (34.0%) | 2 (2.1%) |
Employment | |||
 Formally employed | 53 (11.8%) | 34 (9.6%) | 19 (20.2%) |
 Self-employed | 117 (26.0%) | 95 (26.7%) | 22 (23.4%) |
 Unemployed | 269 (59.8%) | 219 (61.5%) | 50 (53.2%) |
 Other | 11 (2.4%) | 8 (2.3%) | 3 (3.2%) |
Current chronic medical illnessa | |||
 Present | 37 (8.2%) | 30 (8.4%) | 7 (7.5%) |
 Not present | 413 (91.8%) | 326 (91.6%) | 87 (92.6%) |
Antiretroviral regimenb | |||
 First line | 425 (95.3%) | 335 (95.2%) | 90 (95.7%) |
 Second line | 21 (4.7%) | 17 (4.8%) | 4 (4.3%) |
WHO disease staging | |||
 Stage 1 | 417 (93.7%) | 334 (94.9%) | 83 (89.3%) |
 Stage 2 | 22 (4.9%) | 14 (4.0%) | 8 (8.6%) |
 Stage 3 | 3 (0.7%) | 2 (0.6%) | 1 (1.1%) |
 Stage 4 | 3 (0.7%) | 2 (0.6%) | 1 (1.1%) |